Skip main navigation

About Takeda
About Takeda

Home > About Takeda > Overview

Skip side navigation

Main contents starts here

Overview

Takeda is a research-based global pharmaceutical company. As the largest pharmaceutical company in Japan and one of the global leaders of the industry. Setting our management philosophy, “Takeda-ism” as the basis of Business, Takeda is committed to striving towards better health for patients worldwide through leading innovation in medicine.
Takeda is enhancing its R&D pipeline by concentrating its management resources.
Takeda's in-house ethical drugs are marketed in around 90 countries worldwide and are recognized as the brand in major countries worldwide.

General Information

(As of March 31, 2010)
Company Name Takeda Pharmaceutical Company Limited
Headquarters   Head Office 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645
TEL: +81 6 6204-2111
FAX: +81 6 6204-2880
Tokyo Head Office 12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668
TEL: +81 3 3278-2111
FAX: +81 3 3278-2000
Founded June 12, 1781
Incorporated January 29, 1925
President Yasuchika Hasegawa
Paid-In Capital ¥63.5 billion
Number of Employees 6,566 (parent), 19,654 (consolidated)
Number of Shareholders 236,480
Scope of Business Manufacturing, marketing and import / export of pharmaceutical drugs, etc.
R&D Facilities Osaka, Tsukuba (Japan), Palo Alto, San Diego, San Francisco, Deerfield(U.S.), London, Cambridge(U.K.), Singapore
Production Facilities Osaka, Hikari, Italy, Ireland, China, Indonesia
Overseas Subsidiaries and affiliates U.S., Canada, U.K., France, Italy, Germany, Austria, Switzerland, Spain, Portugal, Ireland, Netherlands, Sweden, Belgium, Turkey, China, Taiwan, Philippines, Thailand, Indonesia, Singapore, Mexico, Brazil

Organization of Takeda Pharmaceutical Company Limited


Financial Highlights

  FY 2009
(April 2009 - March 2010)
FY 2008
(April 2008 - March 2009)
Net Sales ¥1,466 billion
(US$15,763 million)
¥1,538.3 billion
(US$15,697 million)
Net Income ¥297.7 billion
(US$3,202 million)
¥234.4 billion
(US$2,392 million)
R&D Investment ¥296.4billion
(US$3,187 million)
¥453.0billion
(US$4,623 million)
Earnings Per Share ¥377.19
(US$4.06)
¥289.82
(US$2.96)
Dividends Per Share ¥180.00
(US$1.94)
¥180.00
(US$1.94)
Consolidated Subsidiaries 55 companies 49 companies
Affiliated Companies
Accounted for
by the Equity Method
15 companies 15 companies

[*]Note: The U.S. dollar amounts represent translations of Japanese yen, for convenience only, at the rate of ¥98=US$1 for FY 2008 and ¥100=US$1 for FY 2007.

Stock Performance

TSE 9/2 15:00

Last
3,890
Change
+35

Access

Head Office

Head Office

Tokyo Head Office

Tokyo Head Office

Osaka Research Center

大阪工場

Related Links

Annual Report

Annual Reports 2009
pdf filePDF 5.0MB 130P

Page Top